Home > Insider Trading > Filing (0001079973-19-000339)

Filing Details

Accession Number:: 0001079973-19-000339
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2019-06-05 15:37:51
Reporting Period:: 2019-05-31

Accepted Time:: 2019-06-05 15:37:51
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1128189	Protokinetix Inc.	PKTX	Pharmaceutical Preparations (2834)	943355026

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1516077	Edward Clarence Smith	1845 County Road #214 St. Augustine FL 32084	President & Ceo	Yes	Yes	Yes	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2019-05-31	88,252	$0.15	6,413,883	No	4	P	Indirect	See footnote
Common Stock	Acquisiton	2019-06-03	33,000	$0.15	6,446,883	No	4	P	Indirect	See footnote
Common Stock	Acquisiton	2019-06-04	21,000	$0.16	6,467,883	No	4	P	Indirect	See footnote

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Indirect	See footnote
No	4	P	Indirect	See footnote
No	4	P	Indirect	See footnote

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	61,353,833	Direct
Common Stock	0	Indirect	See footnote

Reported Derivative Holdings

Show Other Fields >>

Sec. Name	Sec. Type	Price	Expiration Date	Amount	Remaning Holdings	Nature of Ownership
Common Stock	Stock Option	$0.09	2023-11-08	5,000,000	5,000,000	Direct
Common Stock	Stock Option	$0.06	2021-08-31	5,000,000	5,000,000	Direct
Common Stock	Stock Option	$0.05	2020-12-31	5,000,000	5,000,000	Direct
Common Stock	Stock Option	$0.08	2019-12-31	5,000,000	5,000,000	Direct

Expiration Date	Amount	Remaning Holdings	Nature of Ownership
2023-11-08	5,000,000	5,000,000	Direct
2021-08-31	5,000,000	5,000,000	Direct
2020-12-31	5,000,000	5,000,000	Direct
2019-12-31	5,000,000	5,000,000	Direct

Footnotes

Shares held by the Clarence E. Smith Trust and purchased on the open market.
This transaction was executed in multiple trades at prices ranging from $0.138 to $0.157. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
This transaction was executed in multiple trades at prices ranging from $0.147 to $0.151. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
This transaction was executed in multiple trades at prices ranging from $0.155 to $0.157. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Shares held by Mr. Smith's retirement account.
Options granted pursuant to Amended 2017 Stock Option and Stock Bonus Plan. On March 31, 2019, 1,250,000 shares vest; thereafter 1,250,000 shares vest each quarter.
Options granted pursuant to 2017 Stock Option and Stock Bonus Plan. On December 31, 2017, 1,250,000 shares vested; thereafter 1,250,000 shares vested each quarter.
Options granted pursuant to 2017 Stock Option and Stock Bonus Plan. On March 31, 2017, 1,250,000 shares vested; thereafter 1,250,000 shares vested each quarter.
Options granted pursuant to 2015 Stock Option and Stock Bonus Plan. On March 31, 2016, 1,250,000 shares vested; thereafter 1,250,000 shares vested each quarter.